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ABSTRACT 
Objective: To optimally target exercise interventions for patients with cancer, it is important 
to identify which patients benefit from which interventions.  
Design: We conducted an individual patient data meta-analysis to investigate demographic, 
clinical, intervention- and exercise-related moderators of exercise intervention effects on 
physical fitness in patients with cancer.  
Data sources: We identified relevant studies via systematic searches in electronic databases 
(PubMed, EMBASE, PsycINFO and CINAHL). 
Eligibility criteria: We analyzed data from 28 randomized controlled trials investigating the 
effects of exercise on upper (UBMS) and lower body muscle strength (LBMS), lower body 
muscle function (LBMF) and aerobic fitness in adult patients with cancer.  
Results: Exercise significantly improved UBMS (β=0.20, 95% confidence interval 
(CI)=0.14;0.26), LBMS (β=0.29, 95%CI=0.23;0.35), LBMF (β=0.16, 95%CI=0.08;0.24) and 
aerobic fitness (β=0.28, 95%CI=0.23;0.34), with larger effects for supervised interventions. 
Exercise effects on UBMS were larger during treatment, when supervised interventions 
included ≥3 sessions per week, when resistance exercises were included and when session 
duration was >60 minutes. Exercise effects on LBMS were larger for patients who were living 
alone, for supervised interventions including resistance exercise and when session duration 
was >60 minutes. Exercise effects on aerobic fitness were larger for younger patients and 
when supervised interventions included aerobic exercise.  
Conclusion: Exercise interventions during and following cancer treatment had small effects on 
UBMS, LBMS, LBMF and aerobic fitness. Demographic, intervention- and exercise-related 
characteristics including age, marital status, intervention timing, delivery mode and 
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frequency, type and time of exercise sessions, moderated the exercise effect on UBMS, LBMS 
and aerobic fitness. 
Introduction 
Patients with cancer often experience physical problems as a result of cancer or cancer 
treatment.[1-3] Previous randomized controlled trials (RCTs) and meta-analyses have 
reported beneficial effects of exercise on physical fitness in patients with cancer.[4-7] Physical 
fitness is defined by the body's ability to carry out daily tasks without excessive fatigue and is 
important for functional independence and QoL.[8, 9] Physical fitness includes, among others, 
upper body muscle strength (UBMS), lower body muscle strength (LBMS), lower body muscle 
function (LBMF), and aerobic fitness.[10]  
 
A reduction in skeletal muscle mass during (neo-) adjuvant chemotherapy has been shown to 
be related to higher treatment toxicity and poorer survival.[11-13] In the general population, 
poor LBMF is related to reduced functional independence and lower QoL[14, 15] and is a 
significant predictor of mortality.[16] Aerobic fitness was reported to be 25% lower in patients 
with breast cancer after chemotherapy than in healthy sedentary women.[17] Functional 
independence is at risk when maximal aerobic fitness decreases below 15 mililiter 
(mL)/kilogram (kg)/minute (min)[18] and aerobic fitness is a well-established predictor of 
QoL[19] and mortality[4, 20] in patients with cancer. Consequently, maintaining and 
improving strength, muscle function and aerobic fitness may be important during and 
following cancer treatment for functional independence, and to improve QoL and potentially 
survival.[8, 9]  
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Previous RCTs and meta-analyses have reported beneficial effects of exercise during and 
following treatment on muscle strength[5-8, 21, 22] and aerobic fitness[4, 6-8, 21, 23, 24] in 
patients with different types of cancer. To effectively target and refine exercise interventions, 
it is important to identify which patients benefit from which exercise programs. In addition, 
characteristics of the interventions may influence their effects on UBMS, LBMS, LBMF or 
aerobic fitness.[25-27]  
 
Previously, we used data collected in the Predicting OptimaL cAncer RehabIlitation and 
Supportive care (POLARIS) study[28] to conduct an individual patient data (IPD) meta-analysis 
to study demographic, clinical, intervention- and exercise-related moderators of exercise 
intervention effects on self-reported QoL and self-reported physical function.[29] Exercise 
effects on QoL and physical function were not significantly different between subgroups of 
patients with different demographic and clinical characteristics. However, moderators of the 
effect of exercise interventions may differ by outcome. Studies investigating moderators of 
the exercise intervention effects on physical fitness are scarce and single RCTs are generally 
underpowered to investigate such moderator effects. The use of IPD from multiple RCTs 
allows testing of moderators with interaction tests in larger samples.[30] Therefore, we aimed 
to identify demographic, clinical, intervention- and exercise-related moderators of the 
exercise intervention effect on UBMS, LBMS, LBMF and aerobic fitness, using IPD available in 
the POLARIS database.[29] 
Methods 
Study and patient selection 
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We identified and obtained data from relevant studies as part of the POLARIS study. A 
description of the methods of study identification and selection has been published previously 
and detailed information on the study inclusion can be found elsewhere.[28, 29] Principal 
investigators of RCTs eligible to be included in the POLARIS study received a letter of invitation 
to join the consortium. After expressing interest, they signed a data sharing agreement. 
Anonymized data from study participants were shared in various formats, which were re-
coded, and checked for completeness and consistency with published results. The study 
protocol was registered in PROSPERO in February 2013 (CRD42013003805).[28] In total, 34 
RCTs evaluating the effects of exercise in patients with cancer were included in the POLARIS 
database. Of these studies, 28 reported UBMS, LBMS, LBMF and/or aerobic fitness and were 
included in the current IPD meta-analysis (Figure 1). Due to a small sample of patients with 
metastatic disease, we excluded 50 patients with metastatic disease and another 15 patients 
for whom this information was missing.  
Data extraction 
Study and patient characteristics (i.e. country where the RCT was conducted, sample size, 
cancer type, mean age, sex and outcome measure), intervention characteristics (i.e. timing, 
mode and duration of intervention delivery) and exercise characteristics (i.e. frequency, 
intensity, type and time, often referred to as FITT-factors) were extracted by two independent 
researchers (MS and LB) and were based on documentation in published papers 
(Supplementary online Table 1).  
Risk of bias assessment 
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We used the risk-of-bias assessment tool of the Cochrane Collaboration[31] to assess the risk 
of bias of the studies based on published papers. In our previous publication, we reported the 
risk of bias on random sequence generation, allocation concealment, incomplete outcome, 
incomplete reporting, adherence and contamination.[29] For the present study, we 
additionally assessed the risk of detection bias by judging blinding of outcome assessor. Two 
authors (MS and LB) independently judged this item as high risk of bias if the outcome assessor 
was not blinded or low risk of bias if the outcome assessor was blinded. If no information on 
blinding of outcome assessor was reported, the principal investigator of the study was 
contacted. 
Outcome measures 
The current IPD meta-analysis focused on UBMS, LBMS, LBMF, and aerobic fitness after 
completion of the exercise intervention (Figure 1). Studies included in the current meta-
analysis measured UBMS with a one-repetition maximum (1RM) chest press (kilogram; kg),[8, 
9, 32-40] maximum elbow flexion (Newton*meter; Nm),[7, 41] maximum grip strength (kg),[6, 
23, 24, 42, 43] number of repetitions of chest press at 30-35% of individual’s body mass 
(No),[44] sum of upper extremity isometric muscle strength measured using a handheld 
dynamometer (Newton; N),[45] sum of best right and left grip strength (kg)[46] or an upright 
row and shoulder press exercise (stage based on number of repetitions and weight held).[47] 
Four studies also reported grip strength in addition to the 1RM chest press or maximum elbow 
flexion and were included in the sensitivity analysis on grip strength.[7, 38-41] LBMS was 
measured using a 1RM leg press (kg)[9, 32-40] or leg extension (kg),[8] maximum isometric 
quadriceps torque (Nm),[6, 23, 43, 48-51] maximum isometric knee extension (Nm),[7, 41] 
number of repetitions of leg press at 100-110% of individual’s body mass (No)[44] or sum of 
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lower body isometric muscle strength (hip abductors and flexors and knee flexors and 
extensors) measured using a handheld dynamometer (N).[45] LBMF was measured using the 
chair rise (time in seconds to rise from the chair 5 times)[32, 33, 35-40, 44] or sit-to-stand test 
(number of times that participants raised to a full stand in 30 seconds; No).[7, 24, 41, 43] 
Aerobic fitness was measured using a direct (maximal) or indirect (submaximal) 
cardiopulmonary exercise test (CPET; peak oxygen uptake, VO2peak, in ml/kg/min),[6, 8, 23, 
24, 32, 33, 42-44, 48, 52-54] during an endurance test (seconds) at 75% of maximal workload 
measured during a maximal short exercise capacity (MSEC),[7, 41] as distance (meters) walked 
in twelve[55] or six minutes,[45, 56] during a 400-meter walk test (seconds),[32, 35-37] a 
modified Balke-test (time in seconds to reach 70% of age-predicted maximum heart rate 
during submaximal treadmill test)[46] or a three-minute step test (heart rate; HR at test 
completion).[47]  
To be able to pool the different measures per outcome, we recoded individual scores into z-
scores by calculating the mean score at baseline from all individuals per outcome measure 
and subtracting the mean score from the individual score. The result was divided by the mean 
standard deviation per outcome measure at baseline. We used the z-scores for further 
analyses. If studies used more than one measure to investigate one of the outcomes, we used 
the best-established measure based on the order provided in Figure 1 and Table 2.  
 
Moderators of exercise on physical fitness  
Potential demographic moderators included baseline age, sex, marital status (dichotomized 
into unmarried or living alone vs. married or living with partner) and education level 
(dichotomized into low-medium, including elementary, primary or secondary school, lower or 
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secondary vocational education vs. high, including higher vocational, college or university 
education).[29]  
Potential clinical moderators included body mass index (BMI), type of cancer (categorised into 
breast, male genitourinary, haematological, gastrointestinal, gynaecological, respiratory tract, 
or other types) and type of treatment (surgery, chemotherapy, radiotherapy, hormone 
therapy or stem cell transplantation; all dichotomised into previous or current treatment vs. 
no treatment). Since the majority of patients were women with breast cancer, we also 
investigated the moderator effect of type of cancer by dichotomizing patients with breast 
cancer vs. patients with other types of cancer.  
Potential intervention-related moderators included timing of intervention delivery in relation 
to primary cancer treatment (categorised into during treatment and post-treatment, based 
on the Physical Activity and Cancer Control framework[57]), delivery mode of intervention 
(supervised when exercise sessions were conducted (partly) under supervision vs. 
unsupervised when exercise sessions were performed at home) and intervention duration 
(categorised into ≤12 weeks, >12-24 weeks, >24 weeks).  
Potential exercise-related moderators (i.e. FITT-factors) included exercise frequency 
(dichotomized into <3 vs. ≥3 sessions per week for supervised exercise and <5 vs. ≥5 sessions 
per week for unsupervised exercise), exercise intensity (categorised into low, medium and 
high intensity based on the American College of Sports Medicine guidelines[58]), exercise type 
(categorised into aerobic; AE, resistance; RE, combined aerobic and resistance; AE+RE and 
combined resistance and impact loading exercise; RE+impact) and session duration 
(categorised into ≤30 minutes, >30-60 minutes or >60 minutes per session). In addition, we 
calculated mean exercise volume (i.e. frequency  session time) per week as a possible 
exercise-related moderator to investigate whether differences in effects as a result of exercise 
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frequency are related to session duration. According to international physical activity 
guidelines,[58] weekly exercise volume was dichotomized into <150 minutes/week vs. ≥150 
minutes/week for both supervised and unsupervised exercise interventions.  
 
Statistical analyses 
We conducted one-step IPD meta-analyses without imputation of missing data to study the 
effects and moderators of exercise on UBMS, LBMS, LBMF and aerobic fitness.[59] First, using 
z-values, we evaluated exercise effects by regressing the post-intervention value of the 
outcome on the intervention, adjusted for the baseline value, using linear mixed model 
analyses. We used a two-level structure (1-patient; 2-study) and accounted for clustering of 
patients within studies by adding a random intercept on study level. In addition, we checked 
whether it was necessary to adjust the overall effect for age, sex, marital status, education 
level, BMI and cancer type but because unadjusted effect sizes were not different from 
adjusted effects, unadjusted effect sizes were reported. Exercise intervention effects (β) and 
95% confidence intervals (CI) were reported and because z-values were used, the effects 
correspond to a Cohen’s d effect size.[60] Second, we conducted sensitivity analyses using raw 
data (i.e. in their own unit of measurement) of the most frequently used outcome measures 
of UBMS, LBMS, LBMF and aerobic fitness (i.e. chest press, grip strength, leg press, chair rise, 
directly-measured VO2peak)(Table 2).  
All potential moderators were analysed in separate models and for each potential moderator 
of exercise intervention effects, we examined significance of interaction terms with the 
likelihood ratio test. We reported Chi-square (χ2) values, degrees of freedom (df) and p-values. 
When a significant interaction was found, exercise intervention effects and 95% CI were 
reported per stratum. If a significant interaction of a continuous variable was found, exercise 
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intervention effects were reported for subgroups to facilitate interpretation of the results. In 
case a three-armed RCT had two exercise study arms with different exercise characteristics, 
we tested the difference between exercise characteristics using dummy variables,[29] 
because interaction testing was not possible for that characteristic. In that case, we reported 
regression coefficients (βdifference_in_effect) and 95% CI of the between-group difference in z-
scores. If there was a significant between group difference, exercise intervention effects were 
reported per stratum. Effects of 0.2 were considered small, 0.5 as moderate and at or above 
0.8 as large.[60, 61] 
To reduce ecological bias (i.e. bias that occurs when trials differ in other study level 
characteristics than the moderator of interest[62]), within trial interaction was separated from 
between trial interaction and the individual values of the moderator were centered around 
the mean study value of that moderator. Due to the significant moderator effect of delivery 
mode on UBMS, LBMS and aerobic fitness, and because exercise characteristics differ between 
supervised and unsupervised exercise interventions, we investigated moderator effects of 
FITT-factors for supervised and unsupervised exercise interventions separately. Statistical 
analyses were performed using SPSS version 22.0 and R version 3.2.5.[63]  
Results 
Study characteristics 
The POLARIS database included 28 RCTs that evaluated the effect of exercise on UBMS, LBMS, 
LBMF and/or aerobic fitness (Figure 2). In total, 3515 patients were included, of whom 1944 
were randomized to the intervention group and 1571 to the control group. Nineteen RCTs 
evaluated the effect of exercise on UBMS, 18 on LBMS, 11 on LBMF and 21 on aerobic fitness 
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(Supplementary online Table 1). The mean age of the participants was 54.9 (SD 11.7) years, 
75% were female, 67% were diagnosed with breast cancer, 49% were highly educated and 
76% were married or lived with a partner (Table 1).  
Regarding intervention characteristics, ten RCTs investigated the effects of an exercise 
intervention during treatment, 14 following treatment, three during or following treatment 
and one pre-, during- or following treatment. Twenty-two RCTs investigated the effect of a 
supervised exercise intervention, five investigated an unsupervised exercise intervention and 
one investigated the effect of both an unsupervised and supervised exercise intervention arm. 
Eleven RCTs investigated an intervention duration of ≤12 weeks, seven a duration of >12-24 
weeks, eight a duration of >24 weeks and two reported median intervention duration only 
(Supplementary online Table 1).  
Seventeen RCTs evaluating supervised exercise investigated a frequency of <3 times per week 
and six RCTs evaluated a frequency of ≥3 times per week. Three RCTs evaluating unsupervised 
exercise sessions investigated a frequency of <5 times per week, two RCTs ≥5 times per week 
and one RCT did not report exercise frequency. For both supervised and unsupervised, two 
RCTs investigated the effect of low-moderate intensity exercise, nine investigated moderate 
intensity, 16 investigated moderate-high intensity and one investigated high intensity 
exercise. Eight study arms investigated the effect of AE, five the effect of RE, 14 the effect of 
AE+RE and four the effect of RE+impact training. Eight RCTs investigated the effect of ≤30 
minutes per exercise session, 16 of >30-60 minutes, three of >60 minutes per session and one 
RCT did not report session duration (Supplementary online Table 1).  
Risk of bias assessment 
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We previously reported the risk of bias of 26 of the 28 included RCTs.[29] The risk of bias 
assessment of two RCTs [36, 43] could not be performed at that time because the papers were 
not yet published. Twenty-two RCTs were at low risk for selection bias,[6-9, 23, 24, 32-34, 37-
39, 42, 45-50, 52, 54-56] allocation bias,[6-8, 23, 24, 32-34, 37-39, 42, 44, 45, 47-50, 52-56] 
and attrition bias due to the amount or handling of incomplete data,[6-9, 23, 24, 32, 33, 37-
40, 42, 46-50, 52-55, 64] 21 RCTs were at low risk for bias due to selective outcome 
reporting,[6-9, 23, 24, 32-34, 37, 38, 40, 42, 45-50, 52, 55, 56] 11 RCTs reported high 
adherence to the intervention [6, 23, 34, 38, 40, 42, 44, 45, 47, 52-54] and six RCTs met the 
criteria of low risk of bias regarding limited contamination.[8, 24, 38-40, 42] Risk for detection 
bias was low in 13 RCTs due to adequate blinding of outcome assessors [6, 9, 23, 24, 34, 38-
40, 43, 44, 47, 55, 56, 64] and high in 15 RCTs [7, 8, 32, 33, 36, 37, 42, 45, 46, 48, 50-
54](Supplementary online Table 1). Because the lack of blinding could contribute to an 
overestimation of the overall effects, we investigated whether risk for detection bias was a 
moderator of the exercise effect on UBMS, LBMS, LBMF and aerobic fitness. There was a 
moderator effect of the risk for detection bias on UBMS (χ2=6.86, df=1, p=0.01) and aerobic 
fitness (χ2=14.04, df=1, p<0.01) with larger effects for studies at high risk for detection bias. 
Effects of exercise on physical fitness 
Exercise interventions significantly improved UBMS (β=0.20, 95%CI=0.14;0.26), LBMS (β=0.29, 
95%CI=0.23;0.35), LBMF (β=0.16, 95%CI=0.08;0.24) and aerobic fitness (β=0.28, 
95%CI=0.23;0.34; Table 3). Based on sensitivity analyses using a subset of the data with the 
original measurement unit, exercise significantly improved chest press (1RM) (β=4.86, 
95%CI=3.65;6.07 kg), leg press (1RM) (β=16.56, 95%CI=13.15;19.97 kg), chair rise (β=-0.60, 
95%CI=-0.91;-0.28 seconds) and VO2peak (β=1.80, 95%CI=1.34;2.27 ml/kg/min) compared to 
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the control group. There were no significant between group differences for grip strength 
(β=0.19, 95%CI=-0.39;0.76 kg).  
Demographic and clinical moderators  
Intervention effects on LBMS were significantly larger (χ2=5.12, df=1, p=0.02) for patients who 
were unmarried or living alone (β=0.37, 95%CI=0.23;0.51) than for those who were married 
or lived with their partner (β=0.22, 95%CI=0.14;0.30). Intervention effects on aerobic fitness 
were significantly larger (χ2=6.22, df=1, p=0.01) for younger patients. Effect sizes were 0.41 
(95%CI=0.31;0.52) for patients aged <50 years, 0.22 (95%CI=0.15;0.29) for patients aged 50-
70 years, and 0.23 (95%CI=0.07;0.40) for patients aged >70 years. No other demographic or 
clinical characteristic significantly moderated the effects on UBMS, LBMS, LBMF or aerobic 
fitness (Table 3).  
Intervention-related moderators  
Timing of intervention delivery significantly moderated the effect on UBMS (χ2=4.17, df=1, 
p=0.04). There were larger effects when exercise interventions were delivered during 
treatment (β=0.26, 95%CI=0.17;0.36) than following treatment (β=0.13, 95%CI=0.06;0.21). In 
addition, the moderator effect of timing of the intervention delivery remained significant after 
adjusting for intervention delivery mode. The exercise intervention effects on UBMS, LBMS 
and aerobic fitness were significantly larger for supervised than for unsupervised 
interventions (UBMS βdifference_in_effect=0.19, 95%CI=0.05;0.34, LBMS βdifference_in_effect=0.30, 
95%CI=0.12;0.48 and aerobic fitness βdifference_in_effect=0.23, 95%CI=0.12;0.34). Effects of 
unsupervised exercise interventions on aerobic fitness remained significant, but not for UBMS 
and LBMS. Intervention duration moderated the effect of exercise on aerobic fitness (χ2=8.47, 
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df=1, p=0.05). There were larger effects for an intervention duration of ≤12 weeks (β=0.38, 
95%CI=0.30;0.46), than of >24 weeks (β=0.14, 95%CI=-0.02;0.30). The moderator effect of 
intervention duration was no longer significant after adjustment for delivery mode (χ2=4.36, 
df=1, p=0.11). No other intervention-related characteristics significantly moderated the 
effects on UBMS, LBMS, LBMF or aerobic fitness. 
Exercise-related moderators for supervised exercise  
Exercise frequency significantly moderated the effects of supervised exercise interventions on 
UBMS (χ2=17.11, df=1, p<0.001). There were larger effects for an exercise frequency of ≥3 
times/week (β =0.49, 95%CI=0.28;0.70) than <3 times/week (β=0.16, 95%CI=0.11;0.22; Table 
3). There were larger effects for supervised exercise interventions including RE on UBMS and 
LBMS than exercise without RE (Table 3). There were larger effects for supervised exercise 
interventions including RE on UBMS than a combination of AE+RE (βdifference_in_effect=0.29, 
95%CI=0.14;0.43), while the effect was significantly smaller for LBMS βdifference_in_effect=-0.13, 
95%CI=-0.26;-0.01). There were smaller effects for supervised exercise interventions including 
RE on aerobic fitness than exercise including an AE component (RE vs. AE βdifference_in_effect=-
0.31, 95%CI=-0.49;-0.13, RE vs. AE+RE βdifference_in_effect=-0.23, 95%CI=-0.42;-0.03), except for 
RE+impact vs. AE, for which the difference in effect was not statistically significant 
(βdifference_in_effect=-0.21, 95%CI=-0.48;0.06). Exercise session duration moderated the effects on 
UBMS (χ2=14.01, df=2, p<0.01) and LBMS (χ2=9.07, df=2, p=0.01), with significantly larger 
effects for a session duration of >60 minutes (UBMS; β=0.42, 95%CI=0.24;0.60, and LBMS; 
β=0.51, 95%CI=0.40;0.62) than a session duration of >30-60 minutes (UBMS; β=0.16, 
95%CI=0.09;0.23, and LBMS; β=0.26, 95%CI=0.19;0.34 for LBMS). Weekly exercise volume did 
not moderate the exercise effect for any outcome. 
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Exercise-related moderators for unsupervised exercise  
The effects of unsupervised exercise on aerobic fitness were moderated by session duration 
(χ2=8.86, df=1, p<0.01). There were larger effects for a session duration of 0-30 minutes 
(β=0.28, 95%CI=0.13;0.42) than for a session duration of >30-60 minutes (β=-0.14, 95%CI=-
0.39;0.11). Weekly exercise volume did not moderate the exercise intervention effect on 
aerobic fitness. No other exercise characteristics moderated the effects of unsupervised 
exercise on UBMS, LBMS, LBMF and aerobic fitness. 
Discussion 
Based on IPD meta-analyses of 28 RCTs, there were small effects of exercise interventions on 
UBMS, LBMS, LBMF and aerobic fitness in patients with cancer. The effect on physical fitness 
was moderated by age, marital status, intervention timing, delivery mode, exercise frequency, 
type and time, with differences in moderator effects between the different physical fitness 
outcomes. Effects of exercise interventions in subgroups of patients with different 
demographic and clinical characteristics or studies with different intervention- or exercise 
related characteristics were small-to-moderate.  
The beneficial effects on UBMS and LBMS correspond to the results reported in a previous 
systematic review,[65] but are smaller than reported in a previous aggregate meta-analysis.[5] 
One explanation could be that we included more recent studies in our analysis. Another could 
be that the previous aggregate meta-analysis selected only high-quality RCTs based on the 
validity criteria from the Amsterdam-Maastricht Consensus list for Quality Assessment. Using 
this tool, studies with five or more internal validity characteristics were classified as high 
quality RCTs. In our meta-analysis, we included all studies as the Cochrane risk of bias tool 
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used in this study does not provide a cut-off for high quality RCTs. In addition, the effects might 
be influenced by the methods used to measure muscle strength, as we found statistically 
significant beneficial effects on 1RM chest press, but not on grip strength. This indicates that 
grip strength - despite being often used as indicator of UBMS - may not be reflective of 
changes in UBMS as strength of the finger flexor muscles do not reflect general UBMS. The 
resistance training interventions of the included studies do not list specific training of these 
muscle groups, and absence of change is not unexpected. Finally, variation in the protocol 
used to measure grip strength could affect the results.[66]  
Demographic and clinical moderators  
The exercise intervention effects on LBMS were larger for patients who were unmarried or 
living alone than for those who were married. Our results parallel previous findings of single 
RCTs.[8, 27, 52] Patients who are unmarried or living alone may benefit more from supervised 
or guided exercise because they may have a higher adherence to the exercise program 
because of less time constraints than married patients with children.[27] However, being 
unmarried does not necessarily reflect household composition, and results were not 
consistent for all outcomes. 
Our finding that exercise interventions were more effective in improving aerobic fitness of 
younger patients confirms the results reported in a single RCT.[27] This could be explained by 
higher exercise adherence in younger patients,[67, 68] or inadequate training regimes 
targeting aerobic fitness in older adults. [69] For example, older adults experienced larger 
improvements in aerobic fitness from high-intensity interval training than moderate-intensity 
continuous training.[69] However, a systematic review investigating determinants of exercise 
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adherence in patients with cancer reported inconsistent findings for age,[70] and supervised 
exercise interventions during and following cancer treatment can improve muscle strength 
and aerobic fitness in older patients with prostate or breast cancer. [33, 38, 71, 72] 
Intervention-related moderators  
Our finding that exercise intervention effects on UBMS were larger during than after 
treatment has not been reported in previous studies. The moderator effect remained 
significant after adjusting for intervention delivery mode and methods used to measure UBMS 
did not differ between studies during or following cancer treatment. Upper extremities may 
be particularly susceptible to a decrease in muscle strength due to physical inactivity during 
treatment. Thus, offering exercise intervention during treatment may be particularly 
important for maintaining UBMS.[73, 74] In contrast, daily activities, such as walking and 
cycling, may attenuate the decrease in LBMS, LBMF and aerobic fitness during treatment, 
which could explain why the timing of the intervention did not moderate the effect on these 
outcomes. 
Our finding that supervised exercise interventions had larger effects on UBMS, LBMS and 
aerobic fitness than unsupervised exercise interventions is in line with previous IPD and 
aggregate meta-analyses investigating the exercise effects on self-reported QoL and self-
reported physical function.[29, 75] The larger effects of supervised exercise may have resulted 
from better session attendance and guidance from a physiotherapist or exercise specialist, 
access to better training facilities, higher fidelity of patient exercise monitoring or better 
adherence to the prescribed exercise program.[70] The delivery mode did not moderate the 
effects on LBMF. However, this finding was based on one study, with a large CI around the 
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effect. On the other hand, the methods used to measure LBMF may not be sensitive enough 
to detect change over time[76] or may be vulnerable to ceiling effects.[77] 
Exercise-related moderators 
The exercise intervention effects on physical fitness were significantly moderated by different 
exercise FITT-factors. When aiming to improve UBMS, the ideal frequency of supervised 
exercise interventions appears to be at least 3 times per week. The significantly larger exercise 
effects of 0-30 minutes of exercise per session than >30-60 minutes per session on UBMS was 
unexpected and most likely resulted from the specific combinations of exercise FITT-factors 
rather than session duration alone. We found no moderator effect of weekly exercise volume 
on UBMS. This confirms the results of a single RCT in patients during chemotherapy treatment 
for breast cancer,[78] where no difference in effect on UBMS was reported between a dose 
of three times 25-30 minutes/week of AE and three times 50-60 minutes/week of AE. 
However, these results should be interpreted with caution given the exercise intervention 
focused on AE, which is expected to provide minimal strength adaptation. Only one study 
included in our analysis prescribed a session duration of >60 minutes, which was a resistance 
exercise-only study.[34] This makes it difficult to disentangle whether differences in effect 
result from differences in exercise type or session duration.  
There were larger beneficial effects of exercise on UBMS and LBMS of exercise interventions 
that included a resistance exercise component and larger beneficial effects on aerobic fitness 
of exercise interventions that included an aerobic exercise component. This confirms previous 
findings from a single RCT in patients with breast cancer,[8] and corresponds to the aim of the 
specific exercise intervention. Therefore, general training principles can be applied with 
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patients with cancer. Most importantly, exercise prescriptions must be tailored to maximise 
training effects.[79, 80]  
We found that the effect of unsupervised exercise on aerobic fitness was moderated by 
session duration, but weekly exercise volume did not moderate the effects on aerobic fitness. 
Our findings for unsupervised exercise should be interpreted with caution due to the small 
number of studies investigating the effect of an unsupervised exercise intervention on UBMS, 
LBMS, LBF and aerobic fitness. The difference in effect on aerobic fitness for studies with 
different session duration could be explained by specific combinations of intervention- or 
exercise-related characteristics. 
Because FITT-factors are defined at the study level, there may be less variation in these 
variables and the power to detect moderator effects is smaller than for variables at the patient 
level.[81] To further disentangle the effects of different intervention- or exercise-related 
characteristics, it is necessary to conduct second generation studies that directly compare 
different exercise-related characteristics focusing on one FITT-factor while keeping others 
similar.[8, 24, 71]  
Study limitations and strengths  
A limitation of this IPD meta-analysis is that the literature search was conducted in 2012 and 
focussed on QoL outcomes, and only articles published in English, German or Dutch were 
included. Therefore, we may not have included all recent RCTs evaluating physical fitness.[29] 
However, we also prepared for including data from studies to be published in the years after 
2012 by identifying protocol papers describing such ongoing trials and approaching the 
principal investigators from these studies to discuss transfer of data as soon as possible after 
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completion of data collection. This resulted in further inclusion of data from 12 studies 
published up to 2017 (48% of included studies were published between 2013 and 2017). The 
focus on moderators of the exercise effect on physical fitness is novel and these results are 
less likely to be influenced by recent studies currently not included in the IPD meta-analysis. 
There were significantly larger effects on UBMS and aerobic fitness in studies where the 
outcome assessor was not blinded. However, intervention characteristics differed across 
studies judged as being at high risk for detection bias. Therefore, we expect this influence to 
be minimal on our results regarding moderator effects of study level characteristics. 
We did not investigate the moderator effect of combinations of anti-cancer treatments of the 
exercise effect on UBMS, LBMS, LBMF or aerobic fitness because treatment is highly 
correlated with cancer type. Future research should investigate the moderator effect of 
different anti-cancer treatments in more homogeneous groups of patients. Strengths of the 
current IPD meta-analysis are the large number of included RCTs and patients, allowing the 
testing of moderator effects, using uniform analytic procedures across all RCTs. In addition, 
the POLARIS database is, to date, the most comprehensive IPD dataset with exercise oncology 
RCTs. 
Conclusion 
Exercise interventions, particularly those with a supervised component, had beneficial effects 
on UBMS, LBMS, LBMF and aerobic fitness in patients with cancer with different demographic 
and clinical characteristics, both during and following treatment. Exercise intervention effects 
on aerobic fitness were larger for younger patients, and the effects on LBMS were larger for 
patients who are unmarried or living alone. Exercise intervention effects on UBMS were larger 
during than after treatment and for supervised exercise with ≥3 vs. less sessions per week.  
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Figure 1. Flow of data inclusion. 
1 RM = 1-repetition maximum, kg = kilogram, m = meter, ml = milliliter, N = Newton, Nm = newton*meter, No = number of repetitions, RCT = randomized controlled trial, 
sec = seconds, stage = based on number of repetitions and weight held, VO2peak = peak oxygen consumption.  
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Figure 2. Forest plots of the effect sizes (ES) of exercise intervention effects on upper body muscle strength (a), 
lower body muscle strength (b), lower body muscle function (c) and aerobic fitness (d). Data represent the 
regression coefficients [95% confidence intervals] of the effects of exercise on physical fitness (in z-scores). 
Supervised interventions are presented above the dashed line, and unsupervised interventions below. Pooled 
effects are presented at the bottom of the figures. 
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Table 1. Demographic, clinical, intervention- and exercise-related characteristics of patients in the exercise and 
control group. 
 Exercise (n=1944) Control (n=1571) 
Demographic   
Age, mean (SD) years 54.9 (11.9) 55.0 (11.6) 
Age categories, n (%)    
     < 50 years 648 (33.3) 501 (31.9) 
     50-70 years 1070 (55.0) 892 (56.8) 
     ≥ 70 years 216 (11.1) 165 (10.5) 
     Unknown 10 (0.5) 13 (0.8) 
Sex, n (%)   
     Men  496 (25.5) 396 (25.2) 
     Women  1448 (74.5) 1175 (74.8) 
Married/living with partner, n (%)    
     Yes  1150 (59.2) 891 (56.7) 
     No 336 (17.3) 294 (18.7) 
     Unknown 458 (23.6) 386 (24.6) 
Education level, n (%)    
     Low/middle 864 (44.4) 657 (41.8) 
     High  816 (42.0) 632 (40.2) 
     Unknown 264 (13.6) 282 (18.0) 
Clinical   
BMI, mean (SD) kg/m2 27.08 (5.0) 27.42 (5.3) 
BMI categories, n (%)   
     Underweight (BMI <18.5 kg/m2) 13 (0.7) 18 (1.2) 
     Normal weight (BMI 18.5 to < 25 kg/m2) 697 (35.9) 513 (32.7) 
     Overweight (BMI 25 to <30 kg/m2) 676 (34.8) 549 (35.0) 
     Obese (BMI ≥ 30 kg/m2) 447 (23.0) 390 (24.8) 
     Unknown 111 (5.7) 101 (6.4) 
Cancer Type, n (%)   
     Breast 1297 (66.7) 1056 (67.2) 
     Male genitourinary 287 (14.8) 221 (14.1) 
     Haematological 190 (9.8) 183 (11.7) 
     Gastrointestinal 126 (6.5) 76 (4.8) 
     Gynaecological 16 (0.8) 17 (1.1) 
     Respiratory track 23 (1.2) 15 (1.0) 
     Other 5 (0.3) 3 (0.2) 
Surgery, n (%)a     
    No 265 (14.3) 219 (14.8) 
    Yes  1458 (78.8) 1144 (77.5) 
    Unknown 127 (6.9) 113 (7.7) 
Chemotherapy, n (%)   
     No 498 (25.6) 412 (26.2) 
     Prior to intervention 663 (34.1) 618 (39.3) 
     During intervention 715 (36.8) 479 (30.5) 
     Unknown 68 (3.5) 62 (4.0) 
Radiotherapy, n (%)   
     No 850 (43.7) 616 (39.2) 
     Prior to intervention 720 (37.0) 650 (41.4) 
     During intervention 297 (15.3) 253 (16.1) 
     Unknown 77 (4.0) 52 (3.3) 
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Table 1. (continued) 
 Exercise (n=1944) Control (n=1571) 
Hormone therapy   
     Breast cancer survivors (n= 2353), n (%)   
          No 672 (51.8) 545 (51.6) 
          Yes  365 (28.1) 261 (24.7) 
          Unknown  260 (20.1) 250 (23.7) 
     Prostate cancer survivors (n=508), n (%)   
          No 0 (0.0) 0 (0.0) 
          Prior to intervention 50 (17.4) 50 (22.6) 
          During intervention 190 (66.2) 125 (56.6) 
          Unknown 47 (16.4) 46 (20.8) 
SCT, n (%)b   
     Allogeneic 40 (42.6) 40 (42.1) 
     Autologous 54 (57.5) 55 (57. 9) 
Intervention-relatedc    
Timing of intervention, n (%)   
     Pre-during-following treatment 40 (2.1)  
     During treatment 1113 (57.3)  
     Following treatment 791 (40.7)  
Mode of intervention delivery, n (%)   
     (Partly) Supervised  1527 (78.6)  
     Unsupervised 417 (21.5)  
Duration of intervention, n (%)   
    ≤12 weeks 644 (33.1)  
    > 12 - 24 weeks 495 (25.5)  
    >24 weeks 605 (31.1)  
    Unknownd 200 (10.3)  
Exercise-related   
Exercise frequency, n (%)   
     2 times per week 1250 (64.3)  
     3 times per week 286 (14.7)  
     4 times per week 192 (9.9)  
     ≥5 times per week 193 (9.9)  
     Unknown 23 (1.2)  
Exercise Intensity, n (%)   
     Low 0 (0.0)  
     Low-moderate 167 (8.6)  
     Moderate 510 (26.2)  
     Moderate-vigorous 985 (50.7)  
     Vigorous  91 (4.7)  
     Unknown 191 (9.8)  
Exercise type, n (%)   
     AE 437 (22.5)  
     RE 385 (19.8)  
     AE + RE 957 (49.2)  
     RE + Impact training 165 (8.5)  
Exercise session duration, n (%)   
     ≤30 minutes 544 (28.0)  
     >30 – 60 minutes 1148 (59.1)  
     >60 minutes 186 (9.6)  
     Unknown 66 (3.4)  
BMI = body mass index, kg = kilogram, m = meter, n = number, SCT= stem cell transplantation, SD = standard 
deviation; a proportion of survivors without SCT (n= 3326); b proportion of survivors with SCT (n= 189); c 
proportion of survivors from intervention groups (n= 1944);d Intervention duration of individual patients 
unknown for three studies, but mean or median was reported 
26 
 
Table 2. Baseline upper body muscle strength, lower body muscle strength, lower body muscle function and 
aerobic fitness of patients in the exercise and control group. 
 n  Exercise (n=1944) n Control (n=1571) 
Baseline values  Mean (SD)  Mean (SD) 
UBMS, mean (SD)  
   Chest press (1RM) 
   Max elbow flexion (Nm) 
   Grip strength (kg) 
   Chest press (No) 
   Sum upper extremity (N) 
   Sum of best right and left grip 
strength (kg) 
   Row and shoulder press (stage)  
 
658 
150 
378 
8 
40 
68 
134 
 
35.2 (16.1) 
30.5 (12.1) 
35.3 (10.7) 
0.0 (0.0) 
152.7 (46.8) 
69.6 (23.1) 
7.0 (2.8) 
 
512 
72 
290 
7 
39 
33 
60 
 
32.4 (16.8) 
28.7 (13.0) 
36.4 (9.8) 
0.3 (0.8) 
155.4 (54.7) 
72.4 (21.4) 
6.3 (3.6) 
LBMS, mean (SD)   
104.0 (42.9) 
54.1 (26.1) 
105.5 (35.0) 
  
99.6 (44.3) 
56.4 (27.7) 
103.9 (36.4) 
63.8 (17.6) 
16.3 (6.2) 
186.7 (63.2) 
   Leg press (1RM) 
   Leg extension (1RM) 
   Max quadriceps torque (Nm) 
498 
160 
268 
430 
82 
309 
   Max knee extension (Nm) 
   Leg press (No) 
   Sum lower extremity (N) 
153 
8 
40 
69.5 (19.7) 
11.1 (7.6) 
185.5 (54.8) 
77 
7 
39 
LBMF, mean (SD) 
   Chair rise (sec) 
   Sit to stand (No) 
 
339 
406 
 
12.2 (3.2) 
17.5 (5.2) 
 
273 
230 
 
12.0 (3.1) 
16.2 (4.2) 
Aerobic fitness, mean (SD)   
23.1 (6.8) 
773.5 (536.2) 
997.4 (211.0) 
505.6 (107.5) 
273.7 (55.2) 
375.1 (284.4) 
122.5 (16.1) 
  
23.7 (7.5) 
684.8 (515.8) 
975.4 (234.6) 
499.0 (118.5) 
271.3 (46.6) 
351.1 (289.7) 
115.2 (14.7) 
   VO2peak (ml/kg/min) 824 677 
   Endurance test (sec) 168 85 
   12 minute walk test (m) 99 100 
   6 minute walk test (m) 
   400m walk test (sec) 
   Modified Balke test (sec) 
   Step test (HR) 
66 
190 
69 
117 
64 
128 
33 
46 
The outcomes are displayed in the order of which outcome was used in the analyses when more than one 
measure was reported.  
1RM = 1-repetition maximum, AE= aerobic exercise, kg = kilogram, LBMF= lower body muscle function, LBMS= 
lower body muscle strength, ml = milliliter, N = Newton, Nm = newton*meter, No = number of repetitions, RE= 
resistance exercise, SD= standard deviation, sec = seconds, t = time, m = meter, UBMS= upper body muscle 
strength, VO2peak = peak oxygen consumption. 
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Table 3. Effects and moderators of the effects of exercise on upper body muscle strength, lower body muscle strength, lower body muscle function and aerobic fitness. 
 UBMS LBMS LBMF Aerobic fitness 
 χ2 (df), p-value β (95% CI) χ2 (df), p β (95% CI) χ2 (df), p β (95% CI) χ2 (df), p β (95% CI) 
Effect of exercise  0.20 (0.14;0.26)*  0.29 (0.23;0.35)*  0.16 (0.08;0.24)*  0.28 (0.23;0.34)* 
Demographic moderators         
Age continuous 
      Age <50 
      Age 50-70 
      Age >70  
0.10 (1), 0.76 
 
 
 
0.57 (1), 0.45 
 
 0.70 (1), 0.40 
 
 6.22 (1), 0.01*  
      0.41 (0.31;0.52)* 
      0.22 (0.15;0.29)* 
      0.23 (0.07;0.40)* 
Sex 0.97 (1), 0.32  0.59 (1), 0.44  2.17 (1), 0.14  0.00 (1), 0.98  
Marital status 
      Partner  
      Unmarried/living alone 
1.90 (1), 0.17  5.12 (1), 0.02*  
 0.22 (0.14;0.30)* 
 0.37 (0.23;0.51)* 
0.84 (1), 0.36  1.78 (1), 0.18  
Education level 0.02 (1), 0.88  2.71 (1), 0.10  2.03 (1), 0.16  0.97 (1), 0.33  
Clinical moderators         
BMI continuous 0.68 (1), 0.41  0.19 (1), 0.66  1.15 (1), 0.28  0.00 (1), 0.98  
Cancer type  
Breast cancer vs other cancer types 
0.77 (4), 0.94 
0.47 (1), 0.50 
 0.26 (1), 0.61 
0.26 (1), 0.61 
 2.06 (4), 0.73 
0.58 (1), 0.45 
 7.69 (5), 0.17 
0.77 (1), 0.38 
 
Surgery  0.32 (1), 0.57  1.71 (1), 0.19  0.02 (1), 0.88  3.34 (1), 0.07  
Chemotherapy 0.06 (1), 0.81  0.00 (1), 0.95  2.42 (1), 0.12  0.34 (1), 0.56  
Radiotherapy  0.61 (1), 0.43  2.88 (1), 0.09  1.80 (1), 0.18  0.60 (1), 0.44  
Hormone therapy for breast cancer 0.84 (1), 0.36  0.00 (1), 0.96  0.58 (1), 0.45  1.83 (1), 0.18  
Intervention-related moderators         
Timing of intervention 
      During 
      Following  
4.17 (1), 0.04*  
0.26 (0.17;0.36)* 
0.13 (0.06;0.21)* 
0.02 (1), 0.90  1.04 (1), 0.31  2.05 (1), 0.15  
Delivery modea -  Supervised vs  
                                    unsupervised 
      Supervised 
      Unsupervised 
 0.19 (0.05;0.34)* a 
    
0.23 (0.17;0.30)* 
0.11 (-0.06;0.28) 
 0.30 (0.12;0.48)* a 
     
0.30 (0.25;0.36)* 
0.13 (-0.17;0.44) 
 0.02 (-0.16;0.19) a 
 
 0.23 (0.12;0.34)* a 
     
0.34 (0.28;0.40)* 
0.19 (0.07;0.32)* 
Intervention duration 
      ≤12 weeks 
      >12 – 24 weeks 
      >24 weeks 
1.69 (2), 0.43  2.57 (2), 0.28  
   
 
1.10 (2), 0.58  8.47 (2), 0.01*b  
0.38 (0.30;0.46)* 
0.27 (0.17;0.38)* 
0.14 (-0.02;0.30) 
Exercise-related moderators for supervised exercise    
Frequency 
      <3 times/week  
      ≥3 times/week  
17.11 (1), <0.01*  
0.16 (0.11;0.22)* 
0.49 (0.28;0.70)*     
0.01 (1), 0.92  0.05 (1), 0.83  0.29 (1), 0.59  
Intensitya - Moderate-vigorous and  
       vigorous vs. low-moderate and    
       moderate 
 0.11 (-0.04;0.27) a  -0.12 (-0.34;0.09) a  -0.04 (-0.17;0.10) a  0.04 (-0.09;0.17) a 
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Table 3 (continued) 
 UBMS LBMS LBMF Aerobic fitness 
 χ2 (df), p β (95% CI) χ2 (df), p β (95% CI) χ2 (df), p β (95% CI) χ2 (df), p β (95% CI) 
Typea 
       AE+RE vs. AE 
       RE vs. AE 
       RE + impact training vs. AE 
       RE vs. AE+RE 
       RE + impact training vs. AE+RE 
       RE + impact training vs. RE         
  
0.26 (0.07;0.44)* 
0.54 (0.37;0.71)* 
0.27 (0.04;0.50)* 
0.28 (0.14;0.43)* 
0.02 (-0.16;0.19) 
-0.27 (-0.47;-0.07)* 
  
0.42 (0.25;0.59)* 
0.29 (0.14;0.44)* 
0.28 (0.07;0.48)* 
-0.13 (-0.26;-0.01)* 
-0.14 (-0.30;0.02) 
-0.01 (-0.18;0.16) 
  
- 
- 
- 
- 
-0.00 (-0.16;0.16) 
- 
  
-0.08 (-0.22;0.06) 
-0.31 (-0.49;-0.13)* 
-0.21 (-0.48;0.06) 
-0.23 (-0.42;-0.03)* 
-0.13 (-0.37;0.12) 
0.10 (-0.20;0.40) 
Time of exercise session 
       ≤ 30 minutes 
       >30–60 minutes 
       > 60 minutes 
14.01 (2), 0.01*  
    0.49 (0.28;0.70)* 
    0.16 (0.09;0.23)* 
    0.42 (0.24;0.60)* 
9.07 (2), 0.01*  
0.31 (0.15;0.47)* 
0.26 (0.19;0.34)* 
0.51 (0.40;0.62)* 
0.05 (1), 0.83  
 
1.48 (2), 0.48   
 
Weekly exercise volume  3.48 (1), 0.06  1.46 (1), 0.23  0.05 (1), 0.83  0.10 (1), 0.75  
Exercise-related moderators for 
unsupervised exercise 
        
Frequency  0.56 (1), 0.46  -  -  1.47 (1), 0.22  
Intensitya - Moderate-vigorous and 
vigorous vs.      
      low-moderate and moderate 
 -  -  -  0.14 (-0.17;0.45) a 
Typea -  AE+RE vs. AE   0.12 (-0.23;0.47)  -  -  -0.16 (-0.39;0.06) 
Time of exercise session 
       ≤ 30 minutes 
       >30–60 minutes 
0.03 (1), 0.86  -  -  8.86 (1), <0.01*  
0.28 (0.13;0.42)* 
-0.14 (-0.39;0.11) 
Weekly exercise volume  -  -  -  1.47 (1), 0.23  
a Interaction testing for a study-level moderator was not possible and differences between subgroups were tested using dummy variables. Regression coefficients 
(βdifference_in_effect) and 95% confidence intervals (CI) are reported, which represent the between group difference in z-scores. 
b Log likelihood ratio not significant after correction for delivery mode (χ2(2)=4.35, p=0.11). 
AE= aerobic exercise, df = degrees of freedom, LBMS = lower body muscle strength, LBMF = lower body muscle function, RE = resistance exercise, UBMS = upper body 
muscle strength, χ2 = Chi-square, *statistically significant 
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